PARP1 and human African trypanosomiasis: Whilst this sequence difference means that some inhibitors may be less useful in T. brucei treatment than for T. cruzi, the use of the existing inhibitors is still a realistic treatment option for African trypanosomiasis, given the broad activity of PARP inhibitors on TbPARP and the role of TbPARP in parasite development and proliferation.